A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
Search Intensifies for Missing Malawi Military Plane with Vice President Onboard
Denmark Increases Citizenship Application Fee Amidst Public Controversy
High Court Intervenes in Muguka Ban Controversy in Coastal Counties
Real Madrid Threatens Boycott Over LaLiga's Heavy Fixture Schedule and 72-Hour Rest Rule
Euro 2024 Quarterfinal Showdown: England Takes On In-Form Switzerland in Duesseldorf
